Market Place
Sourcing Support
Structure Therapeutics to Join Jefferies London Healthcare Conf
15 Nov 2024 //
GLOBENEWSWIRE
Structure Therapeutics Doses First Patients in Phase 2b Study
13 Nov 2024 //
GLOBENEWSWIRE
Structure Therapeutics Reports Q3 2024 Results & Highlights
13 Nov 2024 //
GLOBENEWSWIRE
Structure Therapeutics Announces ObesityWeek® 2024 Presentations
31 Oct 2024 //
GLOBENEWSWIRE
Structure Therapeutics Promotes Blai Coll to Chief Medical
17 Sep 2024 //
GLOBENEWSWIRE
Structure Therapeutics Appoints Angus C. Russell to Board of Directors
27 Aug 2024 //
GLOBENEWSWIRE
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
26 Aug 2024 //
GLOBENEWSWIRE
Structure Therapeutics Reports Q2 2024 Results And Highlights
08 Aug 2024 //
GLOBENEWSWIRE
Structure Closes Upsized Offering, Fully Exercised Underwriter Option
07 Jun 2024 //
GLOBENEWSWIRE
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
05 Jun 2024 //
GLOBENEWSWIRE
Structure`s GSBR-1290 Shows Positive Obesity, PK Study Data
03 Jun 2024 //
GLOBENEWSWIRE
Structure Proposes ADS, Pre-Funded Warrants Public Offering
03 Jun 2024 //
GLOBENEWSWIRE
Structure Therapeutics Q1 2024 Financials And Highlights
09 May 2024 //
GLOBENEWSWIRE
Structure Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results
08 Mar 2024 //
GLOBENEWSWIRE
Structure`s diabetes pill misses weight-loss expectations in mid-stage trial
19 Dec 2023 //
REUTERS
Structure Therapeutics Reports Third Quarter 2023 Financial Results
14 Nov 2023 //
GLOBENEWSWIRE
Structure posts early oral obesity data, delays larger readout
30 Sep 2023 //
FIERCE BIOTECH
Structure Therapeutics Announces $300 Million Private Placement Equity Financing
29 Sep 2023 //
GLOBENEWSWIRE
Structure Reports Second Quarter 2023 Financial Results and Recent Highlights
10 Aug 2023 //
GLOBENEWSWIRE
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
03 Aug 2023 //
GLOBENEWSWIRE
Structure Announces Presentations of Oral GLP-1 Receptor Agonist GSBR-1290
07 Jun 2023 //
GLOBENEWSWIRE
Structure Therapeutics to Present at Jefferies Healthcare Conference
31 May 2023 //
GLOBENEWSWIRE
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290
25 May 2023 //
GLOBENEWSWIRE
Structure Therapeutics Announces Poster Presentations at the Conference
18 May 2023 //
GLOBENEWSWIRE
Structure Therapeutics Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Structure Therapeutics Reports 4Q and Full Reports Full 2022 FYR
30 Mar 2023 //
GLOBENEWSWIRE
Structure Therapeutics Announces Closing of Upsized Initial Public Offering
07 Feb 2023 //
GLOBENEWSWIRE
Structure Therapeutics Announces Pricing of Upsized Initial Public Offering
02 Feb 2023 //
GLOBENEWSWIRE
Structure Appoints Eric Dobmeier & Joanne Waldstreicher to Board of Directors
18 Jan 2023 //
BUSINESSWIRE
